| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 02/04/2010 | US20100029689 Phosphodiesterase 4 inhibitors |
| 02/04/2010 | US20100029639 Ion channel modulating compounds and uses thereof |
| 02/04/2010 | US20100029631 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient |
| 02/04/2010 | US20100029611 Sphingosine-1-phosphate (S1P) receptor modulating agents such as 1-((3-fluoro-4-(5(1-phenylcyclopropyl)thiazolo[5,4-b]pyridin-2-yl)phenyl)methyl)azetidine-3-carboxylic acid, used for the treatment of autoimmune diseases; side effect reduction |
| 02/04/2010 | US20100029610 Heteroaryl Compounds and Uses Thereof |
| 02/04/2010 | US20100029600 Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain |
| 02/04/2010 | US20100028905 Characterization of grp94-ligand interactions and purification, screening, and therapeutic methods relating thereto |
| 02/04/2010 | US20100028450 Tolerogenic biodegradable artificial antigen presenting system |
| 02/04/2010 | US20100028424 Multilayer thin film comprising two or more adjacent layers of oppositely charged polyelectrolytes and encapsulated antigenic peptides; vaccine development for hepatitis B virus, HIV, bacteria, parasites, and viruses |
| 02/04/2010 | US20100028418 Gainac specific binding molecules and uses thereof |
| 02/04/2010 | US20100028381 Formulation for delivery of immune response modifiers |
| 02/04/2010 | US20100028371 Preparation of recombinant rotavirus proteins in milk of transgenic non-human mammals |
| 02/04/2010 | US20100028362 Modulation of t helper cell-mediated immune responses |
| 02/04/2010 | US20100028354 Compositions monovalent for cd28 binding and methods of use |
| 02/04/2010 | US20100028350 Preventing il-2 mediated inflammation in epithelial cells |
| 02/04/2010 | US20100028349 activates FGF receptors, regulates the growth and differentiation of cells within the liver, regulates other cell types following secretion from the liver, plays a role in liver chemotaxis, has an oncogenic activity, or serves as an antigen for generating antibodies; treating diabetes or obesity |
| 02/04/2010 | US20100028346 Novel synergistic effects |
| 02/04/2010 | US20100028345 Il-17 receptor a antigen binding proteins |
| 02/04/2010 | US20100028330 Methods of upmodulating adaptive immune response using anti-pd1 antibodies |
| 02/04/2010 | US20100028329 Method for producing glycosylated indole compound and antibody against the compound |
| 02/04/2010 | US20100028313 Compositions and methods for treatment of skin disorders |
| 02/04/2010 | US20100028298 Interferon type i supporting compounds |
| 02/04/2010 | CA2742288A1 Multivalent vaccines based on papaya mosaic virus and uses thereof |
| 02/04/2010 | CA2738510A1 6-substituted isoflavonoid compounds and uses thereof |
| 02/04/2010 | CA2732628A1 Therapeutic agents |
| 02/04/2010 | CA2732323A1 Tgr5 modulators and methods of use thereof |
| 02/04/2010 | CA2732282A1 Aminopropylidene derivative |
| 02/03/2010 | EP2149565A1 Sulfoximine substituted chinazoline derivatives as immune modulators for the treatment of inflammatory and allergic diseases |
| 02/03/2010 | EP2149549A1 Pharmaceutical composition for prevention or treatment of hepatitis |
| 02/03/2010 | EP2148875A1 Compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 02/03/2010 | EP2148862A1 Dihydroquinone and dihydronaphthridine inhibitors of jnk |
| 02/03/2010 | EP2148664A1 Use of antivirals in the treatment of medical disorders |
| 02/03/2010 | EP1511742B1 Kinase inhibitors |
| 02/03/2010 | EP1301208B1 Mannose as intranasal vaccine adjuvant |
| 02/03/2010 | CN101637624A Medical devices containing rapamycin analogs |
| 02/03/2010 | CN100586444C Method of processing ginseng for medicinal use and composition |
| 02/02/2010 | US7655802 Phosphodiesterase 4 inhibitors, including aminoindazole and aminobenzofuran analogs |
| 02/02/2010 | US7655797 Intermediates for making 2,4-pyrimidinediamine compounds |
| 02/02/2010 | US7655795 (3R,4R)-1-[(9-deazahypoxanthin-9-yl)methyl]-3-hydroxy-4-hydroxymethyl-pyrrolidine; reaction of formaldehydewith a cyclic amine and a heteroaromatic compound to give methylene linked cyclic amine deazapurines; cancer, bacterial, protozoal infections or T-cell mediated diseases |
| 02/02/2010 | US7655688 Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 02/02/2010 | US7655663 (2S)-4,4-difluoro-1-(2-{[1-(2-pyrazinyl)piperidin-4-yl]amino}acetyl)-2-pyrrolidine carbonitrile; enzyme inhibitors; diabetes |
| 02/02/2010 | US7655425 Uses of a chemokine receptor able to bind to MCP-1, MIP-1α and/or RANTES |
| 02/02/2010 | US7655261 Medicament and method of treatment of patients with heavy metals |
| 02/02/2010 | US7655238 Fusing to the antigen a Listerial truncated ActA protein; Listeria vaccine strains |
| 02/02/2010 | CA2494583C Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 02/02/2010 | CA2439051C Synthetic human peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus |
| 02/02/2010 | CA2418868C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 02/02/2010 | CA2410305C Preparations comprising combinations of enzyme inhibitors, and the use thereof |
| 02/02/2010 | CA2396158C Dipeptide nitrile cathepsin k inhibitors |
| 02/02/2010 | CA2302779C Recombinant mhc molecules useful for manipulation of antigen-specific t-cells |
| 02/02/2010 | CA2293724C Apaf-1, the ced-4 human homolog, an activator of caspase-3 |
| 02/02/2010 | CA2257973C T cell antigen receptor peptides |
| 02/02/2010 | CA2230885C Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 02/02/2010 | CA2142331C Immunoglobulins devoid of light chains |
| 02/01/2010 | CA2638176A1 Oligonucleotide and use thereof |
| 01/28/2010 | WO2010011837A1 Fused heterocyclic compounds useful as kinase modulators |
| 01/28/2010 | WO2010011772A2 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 01/28/2010 | WO2010011768A1 Tri-cyclic pyrazolopyridine kinase inhibitors |
| 01/28/2010 | WO2010011762A1 Pyrazolopyridine kinase inhibitors |
| 01/28/2010 | WO2010011756A1 Pyrazolopyridine kinase inhibitors |
| 01/28/2010 | WO2010011657A1 Bicyclic heterocycle derivatives as histamine h3 receptor antagonists |
| 01/28/2010 | WO2010011653A1 Tricyclic heterocycle derivatives as histamine h3 antagonists |
| 01/28/2010 | WO2010011581A2 Polysaccharides extract from dendrobium for treating allergic diseases |
| 01/28/2010 | WO2010011347A2 Clip inhibitors and methods of modulating immune function |
| 01/28/2010 | WO2010011316A1 SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS |
| 01/28/2010 | WO2010010288A2 Alkylthiazol carbamate derivatives, preparation thereof and therapeutic use thereof |
| 01/28/2010 | WO2010010112A2 Construct and method for the internalization of cargo molecules into a cell |
| 01/28/2010 | WO2010009845A1 Sulfone substituted quinazoline derivatives as immune-modulators for the treatment of inflammatory and allergic diseases |
| 01/28/2010 | WO2009140089A3 Sulfone compounds which modulate the cb2 receptor |
| 01/28/2010 | WO2009090656A3 Combination therapy of beta-glycolipids and antibodies for the treatment of immune-related disorders |
| 01/28/2010 | US20100022783 Cyclohexanecarboxylic acid compound |
| 01/28/2010 | US20100022643 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers |
| 01/28/2010 | US20100022621 Construction and use of transfection enhancer elements |
| 01/28/2010 | US20100022611 1,5-Diaryl-Pyrazoles As Cannabinoid Receptor Neutral Antagonists Useful As Therapeutic Agents |
| 01/28/2010 | US20100022587 Derivatives of 2-phenyl-3-hydroxyquinoline-4(1h)-one and methods of their preparation and utilization |
| 01/28/2010 | US20100022577 Dry syrup containing loratadine |
| 01/28/2010 | US20100022576 Stable and bioavailable formulations and a novel form of desloratadine |
| 01/28/2010 | US20100022522 HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS |
| 01/28/2010 | US20100022514 Heterocycle Compounds and Methods of Use Thereof |
| 01/28/2010 | US20100022502 Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
| 01/28/2010 | US20100022492 Therapeutic causing contraction of mucosal tissue, method of treating diseases relating to mucosal tissues, injector and therapeutic set |
| 01/28/2010 | US20100022482 aSMase inhibitors |
| 01/28/2010 | US20100022470 Method for treating allergic diseases |
| 01/28/2010 | US20100022448 Peptides |
| 01/28/2010 | US20100021991 Methods for Producing Modified Glycoproteins |
| 01/28/2010 | US20100021547 Pharmaceutical composition for piperidinoalkanol compounds |
| 01/28/2010 | US20100021542 Extended release oral dosage composition |
| 01/28/2010 | US20100021503 Immunogenic composition |
| 01/28/2010 | US20100021500 Processes for treating subjects carrying viral infectious agent |
| 01/28/2010 | US20100021485 Combination therapy method and formulation |
| 01/28/2010 | US20100021484 Compositions, Methods and Kits Relating to Poxvirus Subunit Vaccines |
| 01/28/2010 | US20100021470 Monoclonal antibody production by ebv transformation of b cells |
| 01/28/2010 | US20100021469 Functional role of adrenomedullin (am) and the gene related product (pamp) in human pathology and physiology |
| 01/28/2010 | US20100021460 Methods of Treating Autoimmune Diseases Using CD4 Antibodies |
| 01/28/2010 | US20100021459 Polypeptide constructs for intracellular delivery |
| 01/28/2010 | US20100021442 Method for promoting immunotherapy using an agent for elevating dendritic cell precursor level in blood |
| 01/28/2010 | CA2737146A1 Clip inhibitors and methods of modulating immune function |
| 01/28/2010 | CA2731842A1 Compositions and methods for the treatment of hepatitis c |
| 01/28/2010 | CA2731789A1 Alkyl thiazole carbamate derivatives, preparation thereof, and use thereof as faah enzyme inhibitors |
| 01/28/2010 | CA2731498A1 Tri-cyclic pyrazolopyridine kinase inhibitors |